Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients.
Standard
Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. / Mehnert, Anja; Lehmann, Claudia; Graefen, Markus; Huland, Hartwig; Koch-Gromus, Uwe.
in: EUR J CANCER CARE, Jahrgang 19, Nr. 6, 6, 2010, S. 736-745.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients.
AU - Mehnert, Anja
AU - Lehmann, Claudia
AU - Graefen, Markus
AU - Huland, Hartwig
AU - Koch-Gromus, Uwe
PY - 2010
Y1 - 2010
N2 - The aim of this study is to identify anxiety, depression and post-traumatic stress disorder in prostate cancer patients and to investigate the association with social support and health-related quality of life. A total of 511 men who had undergone prostatectomy were surveyed during ambulatory follow-up care for an average of 27 months after surgery using standardised self-report measures (e.g. Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist--Civilian Version, Illness-Specific Social Support Scale, Short-Form Health Survey). Seventy-six per cent of patients evaluated their disease as 'not' or a 'little threatening'. The cancer diagnosis and uncertainty were most frequently reported as 'distressing', while medical treatment and doctor-patient interaction were most frequently evaluated as 'most helpful'. The number of patients reporting increased levels of psychological distress was 16%, with 6% demonstrating signs of having severe mental health problems'. No higher levels of anxiety and depression were observed in cancer patients compared with age-adjusted normative comparison groups. Lack of positive support, detrimental interactions and perceived threat of cancer were found to be predictors of psychological co-morbidity (P <0.001). Lack of positive support, detrimental interactions, threat of cancer, disease stage and age significantly predicted mental health (P <0.001), whereas the impact of social support on physical health was rather weak. Findings emphasise the need for routine psychosocial screening.
AB - The aim of this study is to identify anxiety, depression and post-traumatic stress disorder in prostate cancer patients and to investigate the association with social support and health-related quality of life. A total of 511 men who had undergone prostatectomy were surveyed during ambulatory follow-up care for an average of 27 months after surgery using standardised self-report measures (e.g. Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist--Civilian Version, Illness-Specific Social Support Scale, Short-Form Health Survey). Seventy-six per cent of patients evaluated their disease as 'not' or a 'little threatening'. The cancer diagnosis and uncertainty were most frequently reported as 'distressing', while medical treatment and doctor-patient interaction were most frequently evaluated as 'most helpful'. The number of patients reporting increased levels of psychological distress was 16%, with 6% demonstrating signs of having severe mental health problems'. No higher levels of anxiety and depression were observed in cancer patients compared with age-adjusted normative comparison groups. Lack of positive support, detrimental interactions and perceived threat of cancer were found to be predictors of psychological co-morbidity (P <0.001). Lack of positive support, detrimental interactions, threat of cancer, disease stage and age significantly predicted mental health (P <0.001), whereas the impact of social support on physical health was rather weak. Findings emphasise the need for routine psychosocial screening.
M3 - SCORING: Zeitschriftenaufsatz
VL - 19
SP - 736
EP - 745
JO - EUR J CANCER CARE
JF - EUR J CANCER CARE
SN - 0961-5423
IS - 6
M1 - 6
ER -